Coya Therapeutics (COYA) Projected to Post Earnings on Tuesday

Coya Therapeutics (NASDAQ:COYA) will likely be posting its quarterly earnings results before the market opens on Tuesday, March 18th. Analysts expect Coya Therapeutics to post earnings of ($0.32) per share for the quarter.

Coya Therapeutics Stock Performance

Shares of COYA opened at $6.49 on Friday. The business’s 50-day moving average is $6.28 and its two-hundred day moving average is $6.47. The company has a market capitalization of $108.43 million, a P/E ratio of -9.98 and a beta of 0.31. Coya Therapeutics has a fifty-two week low of $4.75 and a fifty-two week high of $10.69.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. D. Boral Capital reaffirmed a “buy” rating and set a $15.00 price target on shares of Coya Therapeutics in a research report on Monday, March 10th. Chardan Capital reaffirmed a “buy” rating and set a $14.00 price target on shares of Coya Therapeutics in a research report on Thursday, February 6th.

Coya Therapeutics Company Profile

Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.